Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 145

Similar articles for PubMed (Select 20447455)

1.

Risks associated with in utero and lactation exposure to selective serotonin reuptake inhibitors (SSRIs).

Ellfolk M, Malm H.

Reprod Toxicol. 2010 Sep;30(2):249-60. doi: 10.1016/j.reprotox.2010.04.015. Epub 2010 May 4. Review.

PMID:
20447455
2.

Prenatal exposure to selective serotonin reuptake inhibitors and infant outcome.

Malm H.

Ther Drug Monit. 2012 Dec;34(6):607-14. doi: 10.1097/FTD.0b013e31826d07ea. Review.

PMID:
23042258
3.

Paroxetine use during pregnancy: is it safe?

Thormahlen GM.

Ann Pharmacother. 2006 Oct;40(10):1834-7. Epub 2006 Aug 22. Review.

PMID:
16926304
4.

Selective serotonin reuptake inhibitors during pregnancy and risk of persistent pulmonary hypertension in the newborn: population based cohort study from the five Nordic countries.

Kieler H, Artama M, Engeland A, Ericsson O, Furu K, Gissler M, Nielsen RB, Nørgaard M, Stephansson O, Valdimarsdottir U, Zoega H, Haglund B.

BMJ. 2012 Jan 12;344:d8012. doi: 10.1136/bmj.d8012.

5.

Pharmacologic factors associated with transient neonatal symptoms following prenatal psychotropic medication exposure.

Oberlander TF, Misri S, Fitzgerald CE, Kostaras X, Rurak D, Riggs W.

J Clin Psychiatry. 2004 Feb;65(2):230-7.

PMID:
15003078
6.

Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data.

Oberlander TF, Warburton W, Misri S, Aghajanian J, Hertzman C.

Arch Gen Psychiatry. 2006 Aug;63(8):898-906.

PMID:
16894066
7.

Safety concerns associated with the use of serotonin reuptake inhibitors and other serotonergic/noradrenergic antidepressants during pregnancy: a review.

Tuccori M, Testi A, Antonioli L, Fornai M, Montagnani S, Ghisu N, Colucci R, Corona T, Blandizzi C, Del Tacca M.

Clin Ther. 2009 Jun;31 Pt 1:1426-53. doi: 10.1016/j.clinthera.2009.07.009. Review.

PMID:
19698902
8.

Are selective serotonin reuptake inhibitors cardiac teratogens? Echocardiographic screening of newborns with persistent heart murmur.

Merlob P, Birk E, Sirota L, Linder N, Berant M, Stahl B, Klinger G.

Birth Defects Res A Clin Mol Teratol. 2009 Oct;85(10):837-41. doi: 10.1002/bdra.20615.

PMID:
19691085
9.

Selective serotonin-reuptake inhibitors in pregnancy and lactation.

Baum AL, Misri S.

Harv Rev Psychiatry. 1996 Sep-Oct;4(3):117-25. Review.

PMID:
9384984
10.

Neonate characteristics after maternal use of antidepressants in late pregnancy.

Källén B.

Arch Pediatr Adolesc Med. 2004 Apr;158(4):312-6.

PMID:
15066868
11.

SSRI antidepressants and birth defects.

[No authors listed]

Prescrire Int. 2006 Dec;15(86):222-3.

PMID:
17167929
12.

Selective serotonin reuptake inhibitor exposure in utero and pregnancy outcomes.

Lund N, Pedersen LH, Henriksen TB.

Arch Pediatr Adolesc Med. 2009 Oct;163(10):949-54. doi: 10.1001/archpediatrics.2009.164. Erratum in: Arch Pediatr Adolesc Med. 2009 Dec;163(12):1143.

PMID:
19805715
13.

Infant serotonin transporter (SLC6A4) promoter genotype is associated with adverse neonatal outcomes after prenatal exposure to serotonin reuptake inhibitor medications.

Oberlander TF, Bonaguro RJ, Misri S, Papsdorf M, Ross CJ, Simpson EM.

Mol Psychiatry. 2008 Jan;13(1):65-73. Epub 2007 May 22.

PMID:
17519929
14.

Maternal use of selective serotonin re-uptake inhibitors in early pregnancy and infant congenital malformations.

Källén BA, Otterblad Olausson P.

Birth Defects Res A Clin Mol Teratol. 2007 Apr;79(4):301-8.

PMID:
17216624
15.

Risks of congenital malformations and perinatal events among infants exposed to antidepressant medications during pregnancy.

Davis RL, Rubanowice D, McPhillips H, Raebel MA, Andrade SE, Smith D, Yood MU, Platt R; HMO Research Network Center for Education, Research in Therapeutics.

Pharmacoepidemiol Drug Saf. 2007 Oct;16(10):1086-94. Review.

PMID:
17729378
16.

Breastfeeding during maternal antidepressant treatment with serotonin reuptake inhibitors: infant exposure, clinical symptoms, and cytochrome p450 genotypes.

Berle JØ, Steen VM, Aamo TO, Breilid H, Zahlsen K, Spigset O.

J Clin Psychiatry. 2004 Sep;65(9):1228-34.

PMID:
15367050
17.

Risks associated with selective serotonin reuptake inhibitors in pregnancy.

Malm H, Klaukka T, Neuvonen PJ.

Obstet Gynecol. 2005 Dec;106(6):1289-96.

PMID:
16319254
18.

Birth outcomes after prenatal exposure to antidepressant medication.

Hendrick V, Smith LM, Suri R, Hwang S, Haynes D, Altshuler L.

Am J Obstet Gynecol. 2003 Mar;188(3):812-5.

PMID:
12634662
19.

Paroxetine and congenital malformations: meta-Analysis and consideration of potential confounding factors.

Bar-Oz B, Einarson T, Einarson A, Boskovic R, O'Brien L, Malm H, Bérard A, Koren G.

Clin Ther. 2007 May;29(5):918-26. Review.

PMID:
17697910
20.

Neonatal signs after late in utero exposure to serotonin reuptake inhibitors: literature review and implications for clinical applications.

Moses-Kolko EL, Bogen D, Perel J, Bregar A, Uhl K, Levin B, Wisner KL.

JAMA. 2005 May 18;293(19):2372-83. Review.

PMID:
15900008
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk